333 related articles for article (PubMed ID: 21791632)
1. MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.
Daldrup-Link HE; Golovko D; Ruffell B; Denardo DG; Castaneda R; Ansari C; Rao J; Tikhomirov GA; Wendland MF; Corot C; Coussens LM
Clin Cancer Res; 2011 Sep; 17(17):5695-704. PubMed ID: 21791632
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of tumor-associated macrophages during tumor expansion using MRI.
Shih YY; Hsu YH; Duong TQ; Lin SS; Chow KP; Chang C
NMR Biomed; 2011 Dec; 24(10):1353-60. PubMed ID: 22223366
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Particle Imaging of Macrophages Associated with Cancer: Filling the Voids Left by Iron-Based Magnetic Resonance Imaging.
Makela AV; Gaudet JM; Schott MA; Sehl OC; Contag CH; Foster PJ
Mol Imaging Biol; 2020 Aug; 22(4):958-968. PubMed ID: 31933022
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation.
Aghighi M; Theruvath AJ; Pareek A; Pisani LL; Alford R; Muehe AM; Sethi TK; Holdsworth SJ; Hazard FK; Gratzinger D; Luna-Fineman S; Advani R; Spunt SL; Daldrup-Link HE
Clin Cancer Res; 2018 Sep; 24(17):4110-4118. PubMed ID: 29764855
[No Abstract] [Full Text] [Related]
5. Quantification of Nanoparticle Enhancement in Polarized Breast Tumor Macrophage Deposits by Spatial Analysis of MRI and Histological Iron Contrast Using Computer Vision.
Leftin A; Koutcher JA
Contrast Media Mol Imaging; 2018; 2018():3526438. PubMed ID: 30510494
[TBL] [Abstract][Full Text] [Related]
6. Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
[TBL] [Abstract][Full Text] [Related]
7. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma.
Mohanty S; Yerneni K; Theruvath JL; Graef CM; Nejadnik H; Lenkov O; Pisani L; Rosenberg J; Mitra S; Cordero AS; Cheshier S; Daldrup-Link HE
Cell Death Dis; 2019 Jan; 10(2):36. PubMed ID: 30674867
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses.
Shi Q; Pisani LJ; Lee YK; Messing S; Ansari C; Bhaumik S; Lowery L; Lee BD; Meyer DE; Daldrup-Link HE
Contrast Media Mol Imaging; 2013; 8(3):281-8. PubMed ID: 23606432
[TBL] [Abstract][Full Text] [Related]
10. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
11. Novel Clinically Translatable Iron Oxide Nanoparticle for Monitoring Anti-CD47 Cancer Immunotherapy.
Roudi R; Pisani L; Pisani F; Kiru L; Daldrup-Link HE
Invest Radiol; 2024 May; 59(5):391-403. PubMed ID: 37812494
[TBL] [Abstract][Full Text] [Related]
12. Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging.
Chen YW; Liou GG; Pan HB; Tseng HH; Hung YT; Chou CP
Int J Nanomedicine; 2015; 10():6997-7018. PubMed ID: 26635474
[TBL] [Abstract][Full Text] [Related]
13. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
14. MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles.
Al Faraj A; Shaik AS; Afzal S; Al Sayed B; Halwani R
Int J Nanomedicine; 2014; 9():1491-503. PubMed ID: 24711699
[TBL] [Abstract][Full Text] [Related]
15. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages.
Gramoun A; Crowe LA; Maurizi L; Wirth W; Tobalem F; Grosdemange K; Coullerez G; Eckstein F; Koenders MI; Van den Berg WB; Hofmann H; Vallée JP
Arthritis Res Ther; 2014 Jun; 16(3):R131. PubMed ID: 24957862
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.
Grugan KD; McCabe FL; Kinder M; Greenplate AR; Harman BC; Ekert JE; van Rooijen N; Anderson GM; Nemeth JA; Strohl WR; Jordan RE; Brezski RJ
J Immunol; 2012 Dec; 189(11):5457-66. PubMed ID: 23105143
[TBL] [Abstract][Full Text] [Related]
19. PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
Rumney RMH; Coffelt SB; Neale TA; Dhayade S; Tozer GM; Miller G
PLoS One; 2017; 12(12):e0188591. PubMed ID: 29220404
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Visualization of Obesity-Boosted Inflammation in Orthotopic Pancreatic Ductal Adenocarcinoma Using an Octapod Iron Oxide Nanoparticle.
Xu T; Xu X; Yang L; Chen X; Ju S
ACS Appl Bio Mater; 2020 Sep; 3(9):6408-6418. PubMed ID: 35021772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
